Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR

137.8  +2 (+1.47%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ACT. ACT was compared to 67 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT has a correct valuation and a medium growth rate. With these ratings, ACT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
Each year in the past 5 years ACT has been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 11.18%, ACT belongs to the top of the industry, outperforming 98.51% of the companies in the same industry.
ACT's Return On Equity of 26.31% is amongst the best of the industry. ACT outperforms 100.00% of its industry peers.
ACT has a Return On Invested Capital of 14.95%. This is amongst the best in the industry. ACT outperforms 97.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACT is significantly above the industry average of 6.51%.
The last Return On Invested Capital (14.95%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROIC 14.95%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 9.76%, ACT belongs to the best of the industry, outperforming 80.60% of the companies in the same industry.
In the last couple of years the Profit Margin of ACT has grown nicely.
Looking at the Operating Margin, with a value of 14.16%, ACT is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
ACT's Operating Margin has improved in the last couple of years.
ACT has a Gross Margin of 64.27%. This is amongst the best in the industry. ACT outperforms 95.52% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ACT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ACT has been reduced compared to 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ACT has an Altman-Z score of 5.38. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.38, ACT belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
ACT has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
ACT's Debt to FCF ratio of 0.85 is amongst the best of the industry. ACT outperforms 97.01% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that ACT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, ACT is doing good in the industry, outperforming 70.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Altman-Z 5.38
ROIC/WACC2.13
WACC7.03%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ACT has a Current Ratio of 2.48. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.48, ACT is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
ACT has a better Quick ratio (1.52) than 76.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.79%, which is quite impressive.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
The Revenue has been growing slightly by 1.59% in the past year.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%

3.2 Future

Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.19% on average per year.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.78, the valuation of ACT can be described as rather expensive.
ACT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.45, ACT is valued at the same level.
ACT is valuated rather expensively with a Price/Forward Earnings ratio of 21.17.
The rest of the industry has a similar Price/Forward Earnings ratio as ACT.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, ACT is valued at the same level.
Industry RankSector Rank
PE 24.78
Fwd PE 21.17
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACT is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT indicates a somewhat cheap valuation: ACT is cheaper than 68.66% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.61
EV/EBITDA 13.3
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
ACT's earnings are expected to grow with 16.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.73
PEG (5Y)1.01
EPS Next 2Y13.05%
EPS Next 3Y16.33%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 1.33%.
Compared to an average industry Dividend Yield of 3.05, ACT has a dividend in line with its industry peers.
With a Dividend Yield of 1.33, ACT pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 22.58% of its income as dividend. This is a sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.58%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (7/4/2025, 7:00:00 PM)

137.8

+2 (+1.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-30 2025-07-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.40B
Analysts81.82
Price Target121.21 (-12.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.56%
PT rev (3m)14.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.58%
Valuation
Industry RankSector Rank
PE 24.78
Fwd PE 21.17
P/S 2.53
P/FCF 22.61
P/OCF 13.34
P/B 6.83
P/tB 6.95
EV/EBITDA 13.3
EPS(TTM)5.56
EY4.03%
EPS(NY)6.51
Fwd EY4.72%
FCF(TTM)6.09
FCFY4.42%
OCF(TTM)10.33
OCFY7.5%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)1.73
PEG (5Y)1.01
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROCE 20.74%
ROIC 14.95%
ROICexc 17.85%
ROICexgc 18.06%
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
FCFM 11.2%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Debt/EBITDA 0.41
Cap/Depr 163.77%
Cap/Sales 7.78%
Interest Coverage 33.75
Cash Conversion 100.34%
Profit Quality 114.74%
Current Ratio 2.48
Quick Ratio 1.52
Altman-Z 5.38
F-Score7
WACC7.03%
ROIC/WACC2.13
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%